Q2 FY2027 · ended Sep 30, 2026 · Revenue $110.96B, +7.6% YoY · Filed Nov 4, 2026
McKESSON CORPORATION (MCK) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q2 of fiscal 2027, the quarter ended Sep 30, 2026, it reported revenue of $111.0 billion and net income of $1.2 billion. Free cash flow was $3.0 billion. As of Sep 30, 2026 it held $6.5 billion in cash and investments and $11.2 billion in total debt.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- MCK (NYSE)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Irving, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 927653
- Former names
- MCKESSON HBOC INC (until Aug 13, 2001)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2027 Sep 30, 2026 |
Q1 FY2027 Jun 30, 2026 |
Q4 FY2026 Mar 31, 2026 |
Q3 FY2026 Dec 31, 2025 |
Q2 FY2026 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $111.0B | $105.4B | $96.3B | $106.2B | $103.2B |
| Operating income | $1.6B | $1.3B | $2.1B | $1.6B | $1.4B |
| Net income | $1.2B | $614.0M | $1.7B | $1.2B | $1.1B |
| Diluted EPS | $10.44 | $5.15 | $13.69 | $9.59 | $8.92 |
| Operating cash flow | $3.1B | -$220.0M | $3.4B | $1.2B | $2.4B |
| Free cash flow | $3.0B | -$332.0M | $3.3B | $1.1B | $2.3B |
| Total assets | $92.3B | $88.3B | $82.3B | $84.2B | $84.2B |
| Stockholders' equity | -$4.0B | -$4.2B | -$2.2B | -$1.3B | -$1.7B |
| Cash and investments | $6.5B | $5.2B | $4.0B | $3.0B | $4.0B |
| Total debt | $11.2B | $11.7B | $8.8B | $8.6B | $9.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2026 | Aug 25, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
All 1007 McKESSON CORPORATION SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.